Gal-3 blockage decreased obesity-induced cardiac dysfunction, inflammatory markers osteopontin, and CCL2, and fibrosis markers' collagen type I, TGF-β, and connective tissue growth factor (31). The gene discussed is TGFB1; the disease is obesity due to melanocortin 4 receptor deficiency.